| Attribute |
Value |
| 52 Week Change |
-0.7456647 |
| Address1 |
Menara UOA Bangsar |
| Address2 |
Unit A-28-7, Level 28, Tower A No.5 Jln Bangsar Utama 1 |
| All Time High |
322.8 |
| All Time Low |
1.07 |
| Ask |
1.65 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
14,170 |
| Average Daily Volume3 Month |
11,179 |
| Average Volume |
11,179 |
| Average Volume10Days |
14,170 |
| Beta |
2.198 |
| Bid |
1.01 |
| Bid Size |
2 |
| Book Value |
3.218 |
| City |
Kuala Lumpur |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Malaysia |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.26 |
| Current Ratio |
6.081 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
1.26 |
| Day Low |
1.2591 |
| Debt To Equity |
4.155 |
| Display Name |
BioNexus Gene Lab |
| Dividend Yield |
0.0 |
| Ebitda |
-2,640,000 |
| Ebitda Margins |
-0.84436995 |
| Enterprise To Ebitda |
-0.255 |
| Enterprise To Revenue |
0.216 |
| Enterprise Value |
673,808 |
| Eps Trailing Twelve Months |
-1.26 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.46044 |
| Fifty Day Average Change |
-0.20044005 |
| Fifty Day Average Change Percent |
-0.13724634 |
| Fifty Two Week Change Percent |
-74.566475 |
| Fifty Two Week High |
5.888 |
| Fifty Two Week High Change |
-4.6280003 |
| Fifty Two Week High Change Percent |
-0.7860055 |
| Fifty Two Week Low |
1.07 |
| Fifty Two Week Low Change |
0.18999994 |
| Fifty Two Week Low Change Percent |
0.17757003 |
| Fifty Two Week Range |
1.07 - 5.888 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,610,116,200,000 |
| Float Shares |
1,671,006 |
| Free Cashflow |
68,315 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
19 |
| Fullday Change |
-0.060000062 |
| Fullday Change Percent |
-4.5454593 |
| Fullday Price |
1.26 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.12342 |
| Gross Profits |
385,894 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.44721 |
| Held Percent Institutions |
0.0049 |
| Implied Shares Outstanding |
2,933,442 |
| Industry |
Specialty Chemicals |
| Industry Disp |
Specialty Chemicals |
| Industry Key |
specialty-chemicals |
| Ipo Expected Date |
2,023-07-20 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,743,984,000 |
| Last Split Factor |
1:10 |
| Long Business Summary |
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia. |
| Long Name |
BioNexus Gene Lab Corp. |
| Market |
us_market |
| Market Cap |
3,696,137 |
| Market State |
POST |
| Max Age |
86,400 |
| Message Board Id |
finmb_600164494 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-14 |
| Net Income To Common |
-2,575,134 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
4,312,159 |
| Open |
1.2591 |
| Operating Cashflow |
-846,565 |
| Operating Margins |
-3.9868798 |
| Payout Ratio |
0.0 |
| Phone |
60 1 307 241 6898 |
| Prev Name |
BioNexus Gene Lab Corporation |
| Previous Close |
1.32 |
| Price Hint |
4 |
| Price To Book |
0.39154756 |
| Price To Sales Trailing12 Months |
1.1821657 |
| Profit Margins |
-0.82363 |
| Quick Ratio |
4.56 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.060000062 |
| Regular Market Change Percent |
-4.5454593 |
| Regular Market Day High |
1.26 |
| Regular Market Day Low |
1.2591 |
| Regular Market Day Range |
1.2591 - 1.26 |
| Regular Market Open |
1.2591 |
| Regular Market Previous Close |
1.32 |
| Regular Market Price |
1.26 |
| Regular Market Time |
1,792,008,000 |
| Regular Market Volume |
1,078 |
| Return On Assets |
-0.18987 |
| Return On Equity |
-0.33661 |
| Revenue Growth |
-0.966 |
| Revenue Per Share |
1.443 |
| Sand P52 Week Change |
0.17004645 |
| Sector |
Basic Materials |
| Sector Disp |
Basic Materials |
| Sector Key |
basic-materials |
| Shares Outstanding |
2,933,442 |
| Shares Percent Shares Out |
0.0034 |
| Shares Short |
10,111 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
7,488 |
| Short Name |
BioNexus Gene Lab Corp |
| Short Percent Of Float |
0.004 |
| Short Ratio |
1.98 |
| Source Interval |
15 |
| Symbol |
BGLC |
| Total Cash |
3,521,532 |
| Total Cash Per Share |
1.2 |
| Total Debt |
323,197 |
| Total Revenue |
3,126,581 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.26 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.14225 |
| Two Hundred Day Average Change |
-0.8822501 |
| Two Hundred Day Average Change Percent |
-0.41183338 |
| Type Disp |
Equity |
| Volume |
1,078 |
| Website |
https://www.bionexusgenelab.com |
| Zip |
59,000 |